PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.82%
Negative revenue growth while 1475.HK stands at 0.05%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
58.31%
Gross profit growth above 1.5x 1475.HK's 4.61%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
No Data
No Data available this quarter, please select a different quarter.
17.02%
Positive operating income growth while 1475.HK is negative. John Neff might view this as a competitive edge in operations.
-145.72%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-144.83%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-144.83%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-111.34%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-133.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-92.97%
Negative 10Y revenue/share CAGR while 1475.HK stands at 3.70%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
22775.59%
5Y revenue/share CAGR above 1.5x 1475.HK's 3.70%. David Dodd would look for consistent product or market expansions fueling outperformance.
2990.65%
3Y revenue/share CAGR above 1.5x 1475.HK's 3.70%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-222.25%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-149.48%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-263.02%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-517.17%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-3602.95%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-13520.87%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
210.52%
Equity/share CAGR of 210.52% while 1475.HK is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
10.06%
Equity/share CAGR of 10.06% while 1475.HK is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 1475.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 1475.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-34.15%
Firm’s AR is declining while 1475.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
356.23%
Inventory growth of 356.23% while 1475.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-27.14%
Negative asset growth while 1475.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-21.25%
We have a declining book value while 1475.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.31%
We’re deleveraging while 1475.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
531.86%
SG&A growth well above 1475.HK's 5.94%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.